Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
Acute promyelocytic leukemia (APL)
|
Tretinoin
As2O3 |
|
Chronic Mylogenous Leukemia (CML)
|
Imatinib (Ph+)
|
|
Acute Lymphocytic Leukemia (ALL)
|
Imatinib (Ph+)
Asparaginase |
|
Leukemia
|
Glucocorticoids
Aminopterin Tretinoin Imatinib (Ph+) |
|
AIDS-related Kaposi's sarcoma
|
Alitretinoin
|
|
Cutaneous T cell lymphoma
|
Bexarotene
Vorinostat Romidepsin Denileukin |
|
Breast Cancer
|
Tamoxifen
Trastuzumab Lapatinib Fulvestrant (tamoxifen-resistant) Letrozole |
|
Melanoma
|
Vemurafenib (late-stage melanoma)
IL-2 (malignant melanoma) Levamisole (withdrawn from market) Ipilimumab |
|
Gastrointestinal stromal tumors (GIST)
|
Imatinib (cKit target)
Bevacizumab (imatinib resistant GIST) |
|
NSCLC
|
Erlotinib
Gefitinib Bevacizumab |
|
squamous cell carcinoma
|
Cetuximab (absence of K-Ras mut)
|
|
colon cancer
|
Cetuximab (absence of K-Ras mut)
Levamisole (withdrawn from market) |
|
metastatic colorectal cancer
|
Bevacizumab
|
|
Renal cell carcinoma (RCC)
|
Bevacizumab
Sorafenib IL-2 IFN-α 2a IFN-γ |
|
Unresectable hepatocellular carcinoma
|
Sorafenib
|
|
Multiple myeloma
|
Bortezomib
|
|
Myelodysplastic syndrome
|
Azacitidine
5-Aza-2'-deoxycytidine (Decitabine) |
|
Prostate cancer
|
Provenge (metastatic, castration-resistant prostate cancer)
Flutamide |
|
metastatic carcinoma of ovary
|
Topotecan
|